ACTIVE

Ad Hoc Clinical

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

84,5 k €

+46.8% YoY

Gross margin

514,3 k €

-16.6% YoY

Equity

71,2 k €

+0.1% YoY

Workforce

5,0 ETP

-20.6% YoY

What does Ad Hoc Clinical do?

Ad Hoc Clinical is a Public limited company incorporated in 2009. Its main activity is: Other professional, scientific and technical activities n.e.c.. Its registered office is in Ieper. It employs on average 5,0 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0810.857.444

Incorporation

01/04/2009

Legal form

Public limited company

Registered office

Ter Waarde 45 box 1.b
8900 Ieper · FlandreSee on map

Contributed capital

61 500,00 €

Latest accounts

31/12/2025

Average workforce

5,0 ETP

Activities (NACE)

74909Other professional, scientific and technical activities n.e.c.· main 74999Other professional, scientific and technical activities n.e.c.

Joint committees (3)

Contacts

6 public details availableLog in to view

Signals

ProfitableGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009
Income statement
Gross margin	514,3 k €	-16.6%	616,5 k €	-45.9%	1,1 M €	+8.2%	1,1 M €	-4.3%	1,1 M €	+12.4%	978,6 k €	+23.6%	792 k €	-15.8%	940,6 k €	+33.5%	704,8 k €	-0.1%	705,4 k €	+19.2%	592 k €	+24.8%	474,5 k €	-14.0%	551,9 k €	+21.1%	455,7 k €	-0.2%	456,6 k €	+50.5%	303,3 k €	+139%	127 k €
EBITDA	139,6 k €	+14.8%	121,6 k €	-70.0%	405,5 k €	-5.9%	430,7 k €	-15.6%	510,4 k €	+25.0%	408,2 k €	+20.1%	339,9 k €	-19.5%	421,9 k €	+76.2%	239,5 k €	-17.9%	291,6 k €	+3.1%	282,9 k €	+53.3%	184,5 k €	-26.8%	252,1 k €	+39.3%	181 k €	-10.7%	202,7 k €	+15.3%	175,9 k €	+59.9%	110 k €
Operating result	108,9 k €	+18.4%	92 k €	-75.2%	370,3 k €	-6.9%	397,9 k €	-14.6%	465,8 k €	+24.5%	374,2 k €	+21.1%	308,9 k €	-21.0%	391 k €	+88.9%	206,9 k €	-22.3%	266,5 k €	+7.5%	247,9 k €	+104%	121,7 k €	-46.4%	227 k €	+48.9%	152,4 k €	-16.6%	182,8 k €	+12.9%	161,9 k €	+54.2%	105 k €
Net result	84,5 k €	+46.8%	57,5 k €	-78.5%	268,1 k €	-7.7%	290,5 k €	-14.3%	338,9 k €	+23.4%	274,7 k €	+30.3%	210,8 k €	-20.0%	263,4 k €	+107%	127,4 k €	-25.2%	170,4 k €	+12.8%	151,1 k €	+94.1%	77,8 k €	-46.8%	146,3 k €	+50.0%	97,5 k €	-14.2%	113,7 k €	+12.9%	100,6 k €	+49.3%	67,4 k €
Balance sheet
Equity	71,2 k €	+0.1%	71,2 k €	+0.8%	70,6 k €	+0.1%	70,6 k €	+0.9%	69,9 k €	-2.6%	71,8 k €	+36.8%	52,5 k €	+0.4%	52,3 k €	-3.0%	53,9 k €	+0.7%	53,5 k €	-73.7%	203,2 k €	+121%	92,1 k €	+69.7%	54,2 k €	+225%	16,7 k €	+3.4%	16,1 k €	+4.4%	15,5 k €	+4.4%	14,8 k €
Total assets	405 k €	-18.1%	494,8 k €	-37.2%	788 k €	+8.8%	724,1 k €	+5.2%	688,3 k €	+5.1%	654,7 k €	+5.2%	622,4 k €	+2.0%	610,1 k €	-24.4%	807,1 k €	+19.8%	673,6 k €	+30.0%	518,3 k €	-7.1%	557,7 k €	+29.9%	429,2 k €	+48.1%	289,8 k €	+2.4%	283,1 k €	+24.1%	228,1 k €	+34.6%	169,5 k €
Cash	238,7 k €	+7.8%	221,5 k €	-46.8%	416,5 k €	+7.8%	386,3 k €	+29.9%	297,4 k €	+5.0%	283,3 k €	+63.8%	173 k €	-46.0%	320,3 k €	-27.7%	442,9 k €	+15.8%	382,4 k €	+77.6%	215,3 k €	+12.2%	192 k €	-35.1%	295,9 k €	+198%	99,3 k €	-22.9%	128,7 k €	+58.7%	81,1 k €	+3.7%	78,2 k €
Debts	327,3 k €	-22.8%	423,6 k €	-40.9%	717,4 k €	+9.8%	653,5 k €	+5.7%	618,4 k €	+6.1%	582,9 k €	+2.3%	569,9 k €	+2.2%	557,9 k €	-25.9%	753,2 k €	+21.5%	620,1 k €	+96.8%	315,2 k €	-31.6%	460,8 k €	+25.1%	368,4 k €	+34.9%	273,1 k €	+2.3%	267 k €	+31.5%	203 k €	+31.2%	154,7 k €
Other
Workforce	5,0 ETP	-20.6%	6,3 ETP	-30.8%	9,1 ETP	-3.2%	9,4 ETP	+5.6%	8,9 ETP	0.0%	8,9 ETP	-11.0%	10,0 ETP	0.0%	10,0 ETP	+12.4%	8,9 ETP	+7.2%	8,3 ETP	+33.9%	6,2 ETP	+12.7%	5,5 ETP	-5.2%	5,8 ETP	+7.4%	5,4 ETP	+8.0%	5,0 ETP	+163%	1,9 ETP	+1800%	0,1 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

AGOVIA

Director · since 01 janvier 2025 · until 21 juin 2031 · 1017.631.156

Represented by Evelyne Vermeersch

Active

Nancy Cottigny

Director · since 01 janvier 2025 · until 21 juin 2031

Active

Ended mandates

AGOVIA

Director · since 01 janvier 2025 · until 21 juin 2031 · 1017.631.156

Represented by Evelyne Vermeersch

Ended

Nancy Cottigny

Mandate

Ended

Nancy Cottigny

Director

Ended

Nancy Cottigny

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
ICT-WORX● Active	0839.116.613
Vondels● Active	0415.108.728

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	02/07/2026	26/06/2025	05/06/2024	17/07/2023	20/06/2022	05/07/2021
General meeting	20/06/2026	21/06/2025	07/05/2024	17/06/2023	18/06/2022	19/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

18 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	20/06/2026	02/07/2026	Dutch	PDF
Abridged model	31/12/2024	21/06/2025	26/06/2025	Dutch	PDF
Abridged model	31/12/2023	07/05/2024	05/06/2024	Dutch	PDF
Abridged model	31/12/2022	17/06/2023	17/07/2023	Dutch	PDF
Abridged model	31/12/2021	18/06/2022	20/06/2022	Dutch	PDF
Abridged model	31/12/2020	19/06/2021	05/07/2021	Dutch	PDF
Abridged model	31/12/2019	20/06/2020	06/07/2020	Dutch	PDF
Abridged model	31/12/2018	12/05/2019	06/06/2019	Dutch	PDF
Abridged model	31/12/2017	16/06/2018	28/06/2018	Dutch	PDF
Abridged model	31/12/2016	17/06/2017	26/06/2017	Dutch	PDF
Abridged model	31/12/2015	30/06/2016	12/07/2016	Dutch	PDF
Abridged model	31/12/2014	22/06/2015	08/07/2015	Dutch	PDF
Abridged modelCorrection	31/12/2013	10/05/2015	07/07/2015	Dutch	PDF
Abridged model	31/12/2013	21/06/2014	15/07/2014	Dutch	PDF
Abridged model	31/12/2012	24/06/2013	12/07/2013	Dutch	PDF
Abridged model	31/12/2011	23/06/2012	10/07/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	11/07/2011	Dutch	PDF
Abridged model	31/12/2009	12/05/2010	11/06/2010	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 2 active · 4 ended

Active mandates

AGOVIA

Director · since 01 janvier 2025 · until 21 juin 2031 · 1017.631.156

Represented by Evelyne Vermeersch

Active

Nancy Cottigny

Director · since 01 janvier 2025 · until 21 juin 2031

Active

Ended mandates

AGOVIA

Director · since 01 janvier 2025 · until 21 juin 2031 · 1017.631.156

Represented by Evelyne Vermeersch

Ended

Nancy Cottigny

Mandate

Ended

Nancy Cottigny

Director

Ended

Nancy Cottigny

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates03/02/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates03/04/2020
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Registered office03/08/2016
MAATSCHAPPELIJKE ZETEL
PDF
Other09/04/2009
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202584,5 k €↑
2024
Annual accounts 202457,5 k €↓
2023
Annual accounts 2023268,1 k €↓
2022
Annual accounts 2022290,5 k €↓
2021
Annual accounts 2021338,9 k €↑
2020
Annual accounts 2020274,7 k €↑
2019
Annual accounts 2019210,8 k €↓
2018
Annual accounts 2018263,4 k €↑
2017
Annual accounts 2017127,4 k €↓
2016
Annual accounts 2016170,4 k €↑
2015
Annual accounts 2015151,1 k €↑
2014
Annual accounts 201477,8 k €↓
2013
Annual accounts 2013146,3 k €↑
2012
Annual accounts 201297,5 k €↓
2011
Annual accounts 2011113,7 k €↑
2010
Annual accounts 2010100,6 k €↑
2009
Annual accounts 200967,4 k €
01/04/2009
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Ad Hoc Clinical

Overview

What does Ad Hoc Clinical do?

Trend over 17 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline